ArticleFrontiers in microbiology2017
High Prevalence of CTX-M-15-Type ESBL-Producing
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.
- Wild birds as potential reservoirs of antimicrobial-resistantFrontiers in microbiology · 2025Pooled it
- Mobile Genetic Elements as Central Drivers of Antimicrobial Resistance: Molecular Mechanisms, Evolutionary Ecology, One Health Implications and Control Strategies.Antibiotics (Basel, Switzerland) · 2026Review
- Spread of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) in the community living spaces of patients identified as ESBL-E carriers: impact of the housing density in an African context.Tropical medicine and health · 2026Article
- Migratory Birds Facilitate the Spread of Multidrug-Resistant Pathogenic Escherichia coli in Tanguar Haor of Bangladesh.Environmental microbiology reports · 2026Article
- Antibiotic resistance patterns of Escherichia coli isolates in Passeriformes and non-Passeriformes: insights from migratory and resident avifauna.BMC veterinary research · 2026Article
- Surveillance of CTX-M group 1-producingFrontiers in microbiology · 2026Article
- Ecological Diversity of Migratory Birds and Their Associated Bacterial Species in South Korea: A Preliminary Study Including Antimicrobial Resistance Profiles.Veterinary sciences · 2025Article
- Environmental factors driving antimicrobial resistance in Indian flying foxes (Pteropus medius): one health implications.Scientific reports · 2025Article
- Environmental Dispersion of MultiresistantAntibiotics (Basel, Switzerland) · 2025Article
- Extended spectrum beta-lactamase producing Escherichia coli and antimicrobial resistance gene sharing at the interface of human, poultry and environment: results of ESBL tricycle surveillance in Kathmandu, Nepal.One health outlook · 2025Article
- Faecal metagenomes of great tits and blue tits provide insights into host, diet, pathogens and microbial biodiversity.Access microbiology · 2025Article
- Molecular Characterization of Multidrug-ResistantVeterinary sciences · 2024Article
- Prevalence of Antibiotic Resistance and Virulence Genes inMicroorganisms · 2024Article
- Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities.Biomedicines · 2023Review
- Detection and Phylogenetic Analysis of Extended-Spectrum β-Lactamase (ESBL)-Genetic Determinants in Gram-Negative Fecal-Microbiota of Wild Birds and Chicken Originated at Trimmu Barrage.Antibiotics (Basel, Switzerland) · 2023Article
- One health clones of multidrug-resistantOne health (Amsterdam, Netherlands) · 2023Article
- Characterization of Genomic Diversity among Carbapenem-ResistantMicroorganisms · 2022Article
- Longitudinal Study on Extended-Spectrum Beta-Lactamase-Microorganisms · 2022Article
- Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamase ProducingAntibiotics (Basel, Switzerland) · 2022Article
- Occurrence and Characteristics of ESBL- and Carbapenemase- ProducingMicroorganisms · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increased presence of clinically relevant multidrug resistant bacteria in natural environments is an emerging challenge for global health care. Little is known regarding the occurrence of extended-spectrum beta-lactamase producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.